Deborah Birx - 14 Mar 2024 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Executive Officer, Director
Signature
/s/ Deborah Birx
Issuer symbol
ARMP
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
4
Filing time
18 Mar 2024, 20:00:18 UTC
Previous filing
26 Dec 2023
Next filing
25 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Award $0 +60,000 +30% $0.000000 260,000 14 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +240,000 $0.000000 240,000 14 Mar 2024 Common Stock 240,000 $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028.